Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover effective ways to quickly boost your income. Take action today and implement strategies that can help you earn more.
23,725 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Oil climbs toward the $100-per-barrel level as the Iran conflict enters its fourth week. Traders warn that volatility...
Magnum Ice Cream’s public split from Unilever has turned Ben & Jerry’s into a governance flashpoint. The brand’s acti...
Payrolls rose by 115,000 in April, beating forecasts as the unemployment rate held at 4.3%. The report comes as oil-m...
A new AI-driven forecast puts Solana on a trajectory to smash expectations by late 2026, driven by on-chain adoption ...
Costco emerges as a steadier bet than meme-driven plays, backed by membership cash flow and a durable dividend path. ...
Trump-backed candidates swept a Louisiana GOP primary, underscoring ongoing party loyalty. Markets watched political ...
Hongkong Land is reinventing itself after more than a century, shifting from Hong Kong-centric rents to a broader Asi...
Nvidia rode the AI wave on the backs of gamers, but the industry’s shift toward AI workloads and cloud services is ch...
Mortgage demand dropped sharply in the latest MBA survey, with refinances leading the decline as rates trended higher...
A 64-year-old single restaurant owner selling a $1.2 million business discovers 1031 rules won’t cover all gains; a t...
Onity wins approval revised terms for a major reverse mortgage MSR sale to FOA, narrowing the portfolio and shifting ...